Dermatologicals in Denmark

2020 IMPACT

The outbreak of COVID-19 does not impact growth for dermatologicals, however, a decline in demand is seen for some products, due to lockdown restrictions

Overall value growth in dermatologicals is not set to be impacted by the outbreak of COVID-19 in 2020, as growth is predicted to align to that of 2019. However, some areas will see a change in demand due to COVID-19 restrictions.

Hair loss treatments decline as consumers question their effectiveness, and the fashion for a bald or shaved head continues

Hair loss treatments is predicted to record a decline in growth in 2020; however, this is not the result of the COVID-19 pandemic, rather a continued decrease in sales. A decline in this area is due to two factors; firstly, many consumers question the reliability of these products, and therefore, few Danish men believe that these products work.

RECOVERY AND OPPORTUNITIES

Sales of antiparasitics/lice (head and body) treatment will benefit from lockdown being reversed, as the product drives the highest growth across the forecast period

Growth is set to increase in 2021 compared to 2020, boosted by medicated shampoos and antiparasitics/lice (head and body) treatment, with antiparasitics/lice (head and body) treatment seeing an increase as children attend school once again, socialising with friends and increasing the prevalence of lice. In addition, sales of topical allergy remedies/antihistamines, which saw a decline in 2020 compared to 2019, will rise back up, boosting overall sales in the landscape.

The ageing population of the country continues to support growth across the forecast period

The ageing population of the country is also expected to continue driving growth across the forecast period, with older consumers being an ongoing contributor to growth in dermatologicals. This will continue to be the case, as the population of over 65-years-olds is increasing in Denmark, boosting sales of hair loss treatments and other skin treatments.

Following a boost in use due to COVID-19, a preference for discretion will continue to see e-commerce grow across the forecast period

Chemists are expected to continue being the leading distribution channel for dermatologicals across the forecast period; however, as OTC products become increasingly available in retailers as well as through e-commerce, it is expected that their share will continue to decline over the forecast period. In 2020 e-commerce will record strong growth due to the outbreak of COVID-19, as consumers sought to minimise their exposure risk by shopping online.